http://www.cnr.it/ontology/cnr/individuo/prodotto/ID15471
CASC2a gene is downregulated in endometrial cancer. (Articolo in rivista)
- Type
- Label
- CASC2a gene is downregulated in endometrial cancer. (Articolo in rivista) (literal)
- Anno
- 2007-01-01T00:00:00+01:00 (literal)
- Alternative label
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Baldinu P; Cossu A; Manca A; Satta MP; Sini MC; Palomba G; Dessole S; Cherchi PL; Mara L; Tanda F; Palmieri G. (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
- http://ar.iiarjournals.org/content/27/1A/235.full.pdf+html (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroFascicolo
- Note
- Scopu (literal)
- ISI Web of Science (WOS) (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Istituto Chimica Biomolecolare-C.N.R., 07040 Li Punti-Sassari
Servizio di Anatomia Patologica, Azienda U.S.L.1, 07100 Sassari
Dipartimento di Ostetricia e Ginecologia, Università di Sassari, 07100 Sassari
Istituto Zootecnico e Caseario per la Sardegna, Località Bonassai, 07040 Olmedo (SS), Italy (literal)
- Titolo
- CASC2a gene is downregulated in endometrial cancer. (literal)
- Abstract
- Background: Chromosome 10q25-q26 has been
strongly correlated to endometrial tumorigenesis. A novel
human gene, CASC2, has previously been identified at
chromosome 10q26. One out of the three alternative
transcripted forms, CASC2a, has been demonstrated to be
mutated at a low frequency in endometrial cancer (EC). In this
study, the role of the CASC2a gene in cancer has been further
defined. Materials and Methods: Tumour and corresponding
normal tissues were analysed for CASC2a mRNA expression
by real-time RT-PCR and mutation status by PCR-based
approaches. Results: A significantly decreased level of CASC2a
transcripts was observed in 13/17 (76%) EC tissues, as well as
in 6/9 (67%) colorectal cancers. Exogenous expression of
CASC2a in undifferentiated AN3CA endometrial cancer cells
inhibited cellular growth in anchorage-independent growth
assays. Finally, infrequent CASC2a mutations were able to
impair the gene function. Conclusion: Altogether, our findings
strongly suggest that CASC2a may act as a tumour suppressor
gene, with both epigenetic and genetic alterations concurring
to gene inactivation. Down-regulation of CASC2a may provide
a growth advantage in EC cells. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di